Hanmi “Rosuzet is excellent for controlling LDL-C in patients who have had stent implantation”
[메디칼업저버 손형민 기자] Hanmi Pharmaceutical announced on the 25th that the third sub-analysis result of the Rosuzet study (ingredient name Rosuvastatin∙ezetimibe) was recently listed in ‘eClinicalMedicine’ (IF: 17.033), a sister journal of the world-renowned international academic journal The Lancet (IF: 202.731). Since the large-scale clinical ‘Race Study’ using Rosuzet was listed in The Lancet in […]
